Ethyl acrylate (EA) is a known forestomach carcinogen in both rats and mice. Recent work in this laboratory indicated that carcinogenic doses of EA administered by gavage for 13 wk resulted in a sustained increase in forestomach epithelial hyperplasia as long as exposure to EA continued. However, hyperplasia regressed and no forestomach neoplasms were seen after a 19-mo recovery period. Current studies were designed to further investigate the time required for sustained hyperplasia to lead to neoplasia as well as the organ specificity of EA-induced cell proliferation/hyperplasia vs carcinogenicity. EA was administered at 200 mg/ kg (po) to male Fischer-344 rats, 5 days/wk. Squamous cell proliferation/hyperplasia was observed in the forestomach of all rats that received EA for 6 or 12 mo. Treatment of rats with EA for 12 mo followed by 2 mo of recovery resulted in the development of forestomach papillomas in 2 of 5 treated rats. Furthermore, animals treated for 12 mo and allowed 9 mo of recovery exhibited an increase in forestomach squamous cell carcinomas and papillomas at a combined incidence of 4 in 13. In contrast, animals treated with EA for 6 mo and allowed 2 or 15 mo of recovery exhibited a time-dependent regression of cell proliferation and did not develop forestomach neoplasms. No significant elevation in liver cell proliferation or neoplasia was seen at any time in any of the rats included in the present study, further confirming the organ specificity in the relationship between EA-induced cell proliferation and carcinogenicity. In conclusion, EA resulted in increased cell proliferation in the target organ of carcinogenicity (forestomach) but not in nontarget organs such as the liver. This work indicates that cell proliferation, sustained for a sufficient period of time, results in the development of neoplasia despite cessation of chemical administration. Furthermore, a temporal relationship exists between EA-induced epithelial cell proliferation and forestomach carcinogenicity.
INTRODUCTION
Chronic gavage administration of ethyl acrylate (EA) caused dose-and concentration-dependent increases in the incidence of squamous cell papillomas and carcinomas in the nonglandular stomach (forestomach) of both sexes of Fischer-344 (F-344) rats and B6C3F1 mice (27) . No tumorigenicity was observed in other organs; therefore. EA is considered a selective forestomach carcinogen. EA is a major industrial acrylic acid ester used for the production of polymers and copolymers, which are utilized in manufacturing latex paint, textiles, paper coatings, dirt release agents, and certain specialty dental and medical devices ( 19, 27) . This large-scale production and widespread use may result in environmental contamination as well as human exposure and potential toxicity.
Work in this laboratory has focused on the mechanisms responsible for EA-induced forestomach neoplasia and the relationship between acute, subchronic. and chronic toxicity induced in the forestomach by this chemical. Acute gavage administration of EA to rats caused severe mucosal and submucosal edema accompanied b% inflammatory cell infiltration ( 10. 14) . Similar administration of EA for 3 mo caused marked sustained epithelial hyperplasia of the forestomach mucosa. However, when similarly treated rats were examined after re-co very-penods out 8 or 19 mo, there was a slgnlhcant regression of EA-induced forestomach lesions. It was concluded that administration of EA to rats results in persistent forestomach hyperplasia, and this persistence apparently depends on continued exposure to EA ( 16) .
EA is rapidly absorbed, distributed, and metabolized after administration to animals (8, 12) . Al- though inconclusive, negligible binding to nucleic acids was detected in the forestomach or liver of rats receiving radiolabeled EA (12) ; however, significant covalent binding to proteins was detected in both tissues (8, 12) . Covalent protein-bound radioactivity in the forestomach was 4-fold greater than in the liver at 4 hr after EA administration. At 24 hr, covalent protein binding declined in the liver but persisted in the forestomach (12) . Most EA metabolites have been identified. As would be expected, acrylic acid is a major metabolite of this acrylic acid ester (8, 12) . Further studies demonstrated that EA and acrylic acid interact with and deplete endogenous glutathione (11) but provided no evidence of EA epoxidation across the double bond.
Chemically induced cell proliferation is thought to play a role in the promotion and/or progression of chemically induced neoplasia in many organs (5, 24, 29) . More specifically, early proliferative lesions are apparently associated with forestomach tumorigenesis in animals receiving phenolic antioxidants including butylated hydroxyanisole (BHA) (17, 20) .
In another study, a group of forestomach carcinogens and some structurally related noncarcinogenic chemicals were administered, daily for 2 wk, to male rats by gavage. A positive association was found between the induction of epithelial hyperplasia and the carcinogenicity of these chemicals in the forestomach (13) . The current investigations were undertaken to further elucidate the role of cell proliferation in chemically induced forestomach carcinogenesis. In particular, this work focused on determining the time required for persistent increased cell proliferation to induce forestomach neoplasia in rats using the selective forestomach carcinogen, EA. The present work also examined the organ specificity of chemical-induced cell proliferation by assessing the relationship between cell proliferation and carcinogenicity in target (forestomach) and nontarget (liver) organs.
METHODS
Chemicals. EA (99%. inhibited with 15-20 ppm of hydroquinone monomethyl ether) was obtained from Aldrich Chemical Company (Milwaukee, WI). Com oil (Mazola) was obtained from Best Foods, CPC International Inc. (Englewood Cliffs. NJ).
Animals and Treatments. Male F-344 rats were obtained from Charles River Breeding Laboratories (Raleigh, NC). Rats were fed NIH 31 diet and water ad libitum in polycarbonate cages in facilities with a relative humidity of 50 ± 10%, a temperature of 21-22°C, and a 12-hr dark-light cycle. Rats were housed for a minimum of 2 wk prior to treatment and were approximately 3 mo old at the start of chemical administration. Animals were randomly assigned numbers and divided into 3 groups using a computer program that utilizes body weight as the basis of randomization. The mean body weight of each of the 3 groups was 270-271 g at the time of dosing. All animal husbandry and experimental operations were conducted under National Institutes of Health guidelines (36) . EA Administration for 6 or 12 Mo and Recoveries. EA dosing solution was freshly prepared in com oil at 200 mg/5 ml corn oil. Two groups of rats were administered EA by gavage at 200 mg/kg/day (5 ml/ kg), 5 days/wk, for 6 or 12 mo. A third group of rats received com oil at 5 ml/kg for 12 mo. Animals were allowed to recover after cessation of chemical administration and sacrificed as outlined in Fig. 1 .
Five rats from each treatment group were sacrificed using C02 euthanasia at 24 hr after the last dose. Another 5 rats from each treatment group were similarly sacrificed following an 8-wk recovery after the last dose (Fig. 1 ). The remaining rats in these groups were allowed to recover (with no chemical administration) and sacrificed at an approximate age of 24 mo. Because the 6-mo EA treatment/ 15mo recovery group was sacrificed at the same time as the 12-mo EA treatment/9-mo recovery group, 1 control group that received com oil for up to 12 mo followed by a 9-mo recovery was sacrificed at the same time. Five rats from the com oil control group were sacrificed with each sacrifice of the EA groups with the remaining rats sacrificed after 12 mo of com oil dosing and a 9-mo recovery ( Fig. 1 ).
At necropsy, organs and tissues were examined for gross lesions and then preserved in 10% phosphate-buffered neutral formalin. Prior to fixation, stomachs were opened along the lesser curvature and pinned to a piece of cardboard, and the contents were rinsed from the surface. Photographs of representative stomachs were taken for documentation of gross lesions. Stomachs were then cut on the longitudinal axis into 2 halves; one-half was immediately immersed in 10% phosphate-buffered neutral formalin for H&E staining and the other half was fixed in 70% cold ethanol for bromodeoxyuridine (BrDU) immunohistochemical staining (see the following section). Formalin-fixed stomachs were trimmed to include the junction of the forestomach and glandular stomach and the full length of the forestomach. Gross lesions were also trimmed and * Interim sacrifice (5 rats). Microscopic evaluation of coded slides was performed without prior knowledge of treatment. The severity of forestomach mucosal cell hyperplasia was assessed using the following grading scale: 1, minimal; 2, mild; 3, moderate; and 4, marked.
Immunohistochemical Evaluation of BrDU Incorporation into DNA. Replicative DNA synthesis (S-phase nuclei) was assessed in rats (5 per group) receiving EA or com oil for up to 12 mo and following 2or 9-mo recoveries. This assessment was performed immunohistochemically using (BrDU) incorporation following subcutaneous implantation of osmotic minipumps (model 2002; Alza Corporation, Palo Alto, CA) filled with a solution of 25 mg BrDU/ml distilled water. Minipumps (primed for 2-3 hr in sterile saline) were surgically implanted 2 days before sacrifice while rats were under methoxyflurane (metofane; Pitman-Moore, Inc., Washington Crossing, NJ) anesthesia by inhalation.
At necropsy, tissues from these animals were removed as described in the previous section. Ethanol-fixed tissues were processed, embedded, sectioned, mounted on poly-1-lysine-~oated slides, and immunohistochemically stained for BrDU incorporation into cells that underwent S-phase DNA synthesis. Formalin-fixed tissues were similarly processed for preparing H&E-stained sections. BrDU immunohistochemical staining was performed the same as reported elsewhere by Sugihara et al (32) and modified by Eldrige et al (9) .
Extensive BrDU incorporation was observed in the forestomach epithelium of EA-treated rats.
Therefore, quantitative assessment of BrDU incorporation was considered impractical and unnecessary. The labeling index (LI) in the liver was assessed as the percentage of BrDU-laheled hepatocvtes scored in 10 fields. for a total of at least 2.000 he- &dquo; Since the 6-mo treatment/ I 5-mo recovery group was sacrificed at the same time as the 12-mo treatment/9-mo recovery group, I corn oil control group that received corn oil for 12 mo and allowed a 9-mo recovery was sacrificed at this time.
Numbers in parentheses are the mean severity of forestomach hyperplasia using a grading scale of 1-d: 1 = minimal; 2 = mild; 3 = moderate:
patocytes were counted per animal. There was no change in the LI with EA administration, and no data are presented.
RESULTS
Gavage administration of EA (200 mg/kg/day, 5 days/wk) to rats for up to 12 mo resulted in a minimal decrease in body weight gain (data not shown) that was comparatively similar to that observed in the 2-yr carcinogenicity study (27) . However, all control and EA-treated animals were gaining weight at the same rate within 2 mo after cessation of chemical administration.
Administration of EA for 6 mo resulted in nonneoplastic proliferative lesions in the forestomach mucosa of all treated animals. At necropsy, the mucosal surface of the forestomach from each EA-treated rat was thickened and contained I or more 1-3mm-diameter white nodules on the surface of the squamous mucosa. Microscopically, there was hyperplasia (mild to moderate severity) of the squamous epithelium of the forestomach. Hyperplasia consisted of increased thickness of the basal and squamous layers (Table I and Fig. 2a ): in some areas, there was slight increased folding of the mucosa, as evidenced by presence of extensions of the lamina propria into the folded epithelial surface (Fig. 2b) . Microscopically, the focal lesions observed grossly Hyperplasia of forestomach squamous mucosa in rats treated with EA (200 mg,&dquo;kg,,day) for 6 mo (5 days wk) with no recovery period. Note that hs~perplasia in (a) consists primarily of an increase in basal cells (arrows) and (b) has an increase in both basal and squamous epithelium with a more prominent folded mucosa and thick. densely keratinized surface (K). c) Following a consisted of more prominent folding of the mucosa with a thickened keratin layer on the surface. Hyperplasia was multifocal to diffuse in nature and extended along the greater curvature of the forestomach that reached nearly to the entrance of the esophagus. Although hyperplasia was present at the limiting ridge that forms the junction between the glandular and forestomach, it was generally more prominent in the squamous epithelium several millimeters from the limiting ridge. In 1 rat, there was a focal disruption of the muscularis mucosa and downgrowth of the epithelium into the submucosa with formation of a keratin-filled squamous epithelial cyst at that site. No gross or microscopic lesions were present in the forestomach of the vehicle control rats (Table I) . When groups of rats were similarly treated with EA for the same duration and allowed recovery periods of 2 or 15 mo, there were no gross lesions present in the forestomach. With the exception of 1 rat with minimal hyperplasia, the forestomachs of rats in the recovery group (Table I  and Fig. 2c ) could not be distinguished from those of the vehicle controls.
Continued gavage administration of EA (200 mg/ kg/day, 5 days/wk) to rats for 12 mo produced nonneoplastic proliferative lesions in the forestomach that were more severe than those seen at 6 mo (Table  II) . At necropsy, the forestomach mucosa appeared thickened, and focal irregularly shaped white plaques or nodules from 1 to 7 mm in diameter were present -2-mo recovery period, the squamous mucosa cannot be distinguished from that of controls. x 130. on the squamous mucosa of all rats. Microscopically. there was moderate to marked hyperplasia of the squamous epithelium in all rats (Table II) . This was a diffuse change characterized by a thickened squamous epithelium that had a papillarylrugose appearance resulting from numerous folds of the mucosal surface (Fig. 3a ). There was prominent basal cell hyperplasia and a thick keratin layer over the surface of the squamous epithelium. The plaques or nodules observed grossly consisted of focal areas of nodular hyperplasia of squamous epithelium that frequently had downward extensions of basal and squamous epithelial folds into the lamina propria or submucosa; keratin-filled squamous epithelial cysts were present in these focal areas of hyperplasia (Fig. 3b ). Minimal inflammation and fibrosis were sometimes present in areas where focal ulceration of the mucosa had been repaired.
Treatment of rats with EA for 12 mo resulted in a marked increase in the number of BrDU-labeled nuclei in basal and squamous epithelium cells of the forestomach mucosa (Fig. 3c ) in comparison to controls (Fig. 3d ). Extensive nuclei labeling was observed following the 2 days of minipump implantation, indicative of marked replicative DNA synthesis in the forestomach epithelium of rats treated with EA compared to controls. As a result, morphologic evidence of increased hyperplasia was considered in the present study as indicative of increased epithelial cell proliferation as determined by increased incorporation of BrDU into DNA.
When rats were administered EA for the same duration (12 mo) and allowed a recovery period of 2 mo, gross and microscopic treatment-related lesions persisted in the forestomach (Table II and Figs. 4 and 5). Gross lesions in 2 rats of this treatment group consisted of focal irregular-shaped white nodules on the mucosal surface that were approximately 5-8 mm in diameter (Fig. 4C ). Microscopically, these were classified as squamous cell papillomas (Table II ). All 5 rats had focal areas with minimal to mild squamous cell hyperplasia that was clearly less severe than that seen at the end of the 12-mo exposure period (Fig. 5b) . In 3 of these rats, there were focal downgrowths of the squamous mucosa and keratin cyst formation in the mucosa/submucosa (Fig. 5a ). There was extensive BrDU-labeling of cells in the focal areas of hyperplasia or keratin cysts in the submucosa; however, there was minimal evidence of hyperplasia, with major portions of the squamous mucosa in treated rats (Fig.  5c ) could not be distinguished from vehicle controls (Fig. 5d ). Further there was only a slight increase in the amount of BrDU-labeling of basal epithelium compared to controls. Minimal inflammation and fibrosis were sometimes present in the lamina pro-pria : this was generally associated with the presence of hair shafts embedded in the superficial mucosa or in areas with partial disruption of the muscularis mucosa and repair of previous ulcerations.
Gross lesions were present on the forestomach mucosa in 7 of 13 rats that were administered EA for 12 mo and allowed a 9-mo recovery. These lesions consisted of nodular white exoph)1ic masses that ranged from 2 to > 20 mm in diameter (Fig.  4D ). Based on microscopic examination, 1 mass was diagnosed as squamous cell papilloma (Fig. 6a ) and 3 as well-differentiated squamous cell carcinomas ( Fig. 6c ). Carcinomas were locally invasive: cords of neoplastic cells were associated with mild to moderate fibrosis and inflammation of the surrounding lamina propria and submucosa (Fig. 6c ). The carcinomas did not extend into the tunica muscularis, and there was no evidence of metastases to regional lymph nodes or other tissues. The smaller gross lesions identified in the other EA-treated rats consisted of focal areas of mucosal hyperplasia with keratin cyst formation in the mucosa; minimal to mild fibrosis and inflammation were sometimes associated with these cysts or focal areas of hyperplasia.
Examination of livers from control and EA-treated rats revealed no gross or microscopic changes, and no significant difference in the BrDU LI of hepatocytes from EAor vehicle-treated control rats was detected in the present study. Furthermore, no tumors were seen in the liver or any other organ, except the forestomach, of rats treated with EA.
DISCUSSION
Recent studies conducted in this laboratory have focused on mechanisms of chemically induced forestomach carcinogenesis ( 12, (14) (15) (16) with particular emphasis on the relationship between acute and prechronic toxicity and induction of carcinogenicity by chemicals. EA administration for 2 wk resulted in dose-dependent generalized squamous mucosal hyperplasia and hyperkeratosis of the forestomach (10, 15) . Similar work on the effect of several forestomach carcinogens suggested an association between chemical-induced forestomach epithelial cell proliferation and carcinogenesis ( 13) _ Subsequent studies demonstrated that forestomachs of rats receiv-ing EA for 3 mo exhibited focal and multifocal hyperplastic proliferations of the forestomach mucosa. The hyperplastic epithelium showed no evidence of dysplasia: however, downw ard cell proliferation of the epithelial mucosal surface extended deep into the submucosa. After 19 mo of recovery. EA effects were largely reversible with the exception of residual hyperplasia characterized by occasional FIG. 4. -Gross appearance of the stomach mucosa from rats administered com oil or EA by gavage for 12 mo followed by 2 mo of recovery (top row). Compared to the control (A), note white foci (arrows) representing focal hyperplasia of squamous mucosa (B) and squamous cell papilloma (C) arising from the mucosal surface of the forestomach of EAtreated rats. Gross appearance of the mucosal surface of the stomach from rats administered EA by gavage for 12 mo followed by 9 mo of recovery (D) with squamous cell carcinomas arising from each forestomach. Hyperplasia of forestomach squamous mucosa in rats treated with EA (200 m~/kg/day) for 12 mo (5 days/ wk) with no recovery period. Note the increased thickness of hyperplastic mucosa (a) compared to that in Fig. 2 ( x 1 ~0) . Marked hyperplasia (b) of squamous mucosa with downgrou-th of squamous cyst (arrows) into submucosa (x 65). BrDUlabeled mucosa of rat administered EA (c) demonstrates increased labeling in the basal cell layer compared to the forestomach from com oil vehicle (d); x 130. islands of localized downgrowth of basal mucosal cells (16) .
Results of the present work showed that administration of EA to male F-344 rats for 6 mo resulted in sustained mucosal hyperplasia of the forestomach with essentially a complete reversal of EA-induced effects after cessation of chemical administration.
Marked mucosal hyperplasia/cell proliferation was also observed in the forestomach of rats at the end of a 12-mo EA dosing regimen. Morphologic evidence of increased hyperplasia was consistent with increased epithelial cell proliferation as determined by increased incorporation of BrDU into DNA. While significant decrease in the severity of forestomach hyperplasia/cell proliferation was observed in all EA-treated rats after a 2-mo recovery, squamous cell papillomas were detected in 2 of 5 animals. Progression to neoplasia was also seen in rats treated for 12 mo and allowed a 9-mo recovery, as evident from the presence offorestomach squamous cell papillomas and carcinomas.
These data suggest that EA-induced forestomach hyperplasia/cell proliferation is sustained as long as chemical administration continues. However, the current findings have demonstrated that reversibility ofEA effects may depend on the time of exposure to the chemical. Although exposure to EA for 6 mo resulted in persistent mucosal hyperplasia during exposure, a time-dependent reversal was observed after discontinuation of chemical administration. In contrast, when EA was administered for 12 mo, focal mucosal hyperplasia/cell proliferation persisted after cessation of chemical dosing, and a significant increase in the incidence of squamous cell neoplasms of the forestomach was observed. These data demonstrate a temporal relationship between a sustained increase of cell proliferation and EAinduced forestomach carcinogenicity.
Although cancer development is complex, the initiation-promotion-progression model has remained the most acceptable model for explaining chemical carcinogenesis. Based on this model, chemicals are typically classified as initiators, promoters, or complete carcinogens. Cell proliferation is thought to play a role in each of the 3 stages of tumor induction by some genotoxic and nongenotoxic chemicals (6, 33) in organs such as the forestomach (13, 17) , liver (20) , upper respiratory tract (25) , kidney (31) , and urinary bladder (5, 7) . EA is generally considered to be devoid of any tumor-initiating activity. ~1utagenicity studies in several Salmonella t_~phim~riu»r strains and Drosophila indicate that EA is nonmutagenic with or without the presence of metabolic activation systems ( 19. 37) . Additionally. 2 separate mouse micronucleus tests have shown positive and negative responses, respectively (3, 30) . In studies with the L5178Y mouse lymphoma cell system (26) . EA induced a positive response. Identification of EA metabolites (8, 12) provided no evidence for the formation of an epoxide intermediate, and the electron withdrawing potential of the carbonyl group across the double bond suggests that metabolic activation of EA via an epoxide intermediate is unlikely. EA has not been directly tested in vivo using an initiation-promotion protocol. Despite this deficiency and the limitations of short-term mutagenicity tests in predicting carcinogenicity (35) , the available in vitro results in conjunction with the absence of a carcinogenic response in the 6-mo EA administration/ recovery studies strongly suggest that the mechanism of EA-induced forestomach carcinogenesis is completely or largely nongenotoxic. Therefore, other initiating events must be considered in order to explain EA-induced forestomach carcinogenicity.
Initiation of forestomach carcinogenesis may be caused by trace chemical contaminants or natural carcinogens in the diet (1, 2) or the potential formation of N-nitroso compounds in the acid environment of the rat stomach (4) . Members of this family of compounds are well known as potent initiators of carcinogenicity of both the glandular and nonglandular portions of the stomach (18) . Another potential source of initiation of carcinogenesis is endogenous errors arising during DNA replication or repair (23) . Because no tumorigenic response was observed in the 6-mo EA administration/recovery studies, it is possible that these mechanisms of initiation were not operational or that any DNA damage that may have occurred was repaired during that study. However, this does not exclude the possibility that sustained cell proliferation in the 6-mo study was insufficient to promote initiated cells. In contrast to the observation in the 6-mo study, induction of tumors in the 12-mo dosing/recovery regimen confirmed that heritable alterations may have resulted during the additional time. Present findings suggest that the time of exposure and the associated +--FIG. S-Keratin cyst formation (a) and focal hyperplasia (b) in rats administered EA for 1? mo followed by a 9-mo recovery period. x 65. Major portion of squamous mucosa from rats in this recovery group (c) cannot be distinguished from com oil vehicle control (d). x 130. enhancement of epithelial cell proliferation at in-' creased levels may contribute to tumor initiation/ j promotion in the present model. Sustained cell pro-. liferation at elevated levels may increase the probability of spontaneous mutations by shortening the time available for cells to repair damaged DNA prior to replication, thereby &dquo;fixing&dquo; the initiating event (22) . Once forestomach initiation occurs, enhanced cell proliferation may favor the clonal expansion of initiated cells and increase the probability of additional genetic damage in these cells, thereby contributing to tumor promotion and progression in the forestomach (5, 29) . This may explain the continued cell proliferation during the recovery period after the 12-mo exposure to EA compared to the regression during the recovery in the 6-mo dosing regimen. It is therefore possible that while EA does not appear to be genotoxic, genetic alterations may be indirectly facilitated by EA-induced enhancement of epithelial cell proliferation.
The present findings demonstrated that EA-induced preneoplastic lesions can progress despite cessation of chemical administration. Furthermore, progression of EA-induced forestomach lesions from benign to malignant in the absence of chemical administration suggests that the neoplastic process is apparently driven by elevated forestomach cellular proliferation. This suggestion is supported by studies comparing the pattern of reversibility of forestomach lesions induced by genotoxic and/or nongenotoxic carcinogens (21, 34) . Forestomach hyperplasia induced by genotoxic carcinogens such as N-methyl-N&dquo;-nitro-N-nitrosoguanidine (MNNG) has progressed to neoplasia after cessation of treatment. Furthermore, while reversibility of forestomach lesions was observed in rats after 26 wk of exposure to BHA and 20 wk of recovery, progression to neoplasia occurred when a single dose of MNNG preceded exposure to BHA. In another study, progression to neoplasia also occurred, in the absence of an initiating agent, after 12 mo of exposure to BHA followed by 12 mo of recovery (28) . It is therefore clear that the introduction of a genetic altering agent such as MNNG has contributed to the progression of hyperplasia/cell proliferation induced in the forestomach by a nongenotoxic carcinogen. Additionally, extension of the exposure regimen to BHA for 12 mo and the associated enhancement of fore-stomach cell proliferation may have contributed to genetic alteration and progression to neoplasia. The similarities of BHAand EA-induced forestomach lesions and the pattern of their reversibility support the presented hypothesis that sustained enhancement of forestomach cell proliferation has resulted in favorable conditions for genetic alteration. and both events have subsequently resulted in development of neoplasia in the 12-mo treatment and recovery studies by both forestomach carcinogens.
In summary, forestomach hyperplasia/cell proliferation was sustained as long as EA administration continued. Reversal of such effects was time-dependent and cell proliferation remained enhanced after cessation of EA dosing in the 12-mo study but not in the 6-mo dosing protocol. No enhancement of cell proliferation was detected in the liver of EAtreated rats. This work confirms the organ selectivity of EA in enhancing cell proliferation in the target of carcinogenicity and not in nontarget organs. Present work also demonstrated that EA-induced lesions progressed in the absence of chemical administration. While hyperplasia/cell proliferation was detected at the end of the 12-mo dosing regimen, squamous cell papillomas and carcinomas were seen during the recovery period. In conclusion, these data indicate that the time of sustained enhancement of epithelial cell proliferation plays a critical role in EA-induced forestomach carcinogenicity. Finally, while a relationship between sustained enhancement of cell proliferation and carcinogenesis probably exist, caution must be exercised in predicting the potential carcinogenicity of nongenotoxic chemicals on the basis of data obtained from short-term cell proliferation screening assays, exclusively.
